spacer
home > pmps > autumn 2017 > making the switch
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Making the Switch

The global pharmaceutical manufacturing sector revenue is estimated to increase to around $1,226 billion by 2018. To remain competitive in such a large market, these organisations must optimise processes to create low-expense products without compromising quality. The adoption of continuous manufacturing will offer the industry many benefits.

Pharma production is a well-established sector that provides high-quality and affordable medication to the population. However, manufacturers often rely on older processes rather than adapting to meet the growing needs of consumers.

Traditionally, batch manufacturing produces the majority of drugs sold worldwide – a method that isolates each process. Workers will handle the product at each stage, sending it to be tested in laboratories before the next step. While this works effectively, receiving the final item may take months. Companies are looking for new solutions to reduce costs, environmental impact and development time.

In the boom of Industry 4.0, many sectors, such as chemicals and gas, have implemented more advanced technology to optimise production. Integrated automation systems can streamline an assembly line to efficiently create medication and devices frequently, with little human interaction. Continuous manufacturing is an advancement that developers should utilise to reap the same benefits as these industries.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jonathan Wilkins is Marketing Director at EU Automation and is also one of the most prolific Industry 4.0 writers in the industrial automation sector. A professional brand advocate and commercial marketing strategist, he has been part of the company since its humble beginnings in 2009 and has over a decade of experience in marketing.
spacer
Jonathan Wilkins
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI’s Tredegar Site Announces Significant Expansion of Analytical Laboratories at its Center of Excellence for Contained Manufacturing

Philadelphia, USA- March 19, 2018. Global pharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce a laboratory expansion at its site in Tredegar, Wales, UK. 
More info >>

White Papers

Clinical Trials in Russia Orange Paper: Summary of Year 2013

Synergy Research Group

Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

 
Industry Events

ChinaBio Partnering Forum 2018

25-26 April 2018, Kempinski Hotel Suzhou, Jiangsu, China

Access a world of opportunities through life science partnering in China. ChinaBio® Partnering Forum is the premier life science partnering event in China. The conference will be held April 25–26 in Suzhou, attracting biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement